A Sale doctor who is one of the the country’s leading experts on the treatment of Pancreatic cancer, is help run what is described as a new era in pancreatic cancer research with a £1.2 million funding boost for the North West.
Cancer Research UK today announced the funding which is part of a £10 million package nationwide. The money will be used for the PRECISION Panc project which is run by universities in Glasgow, Manchester and Cambridge
The project aims to develop personalised treatments for pancreatic cancer patients, improving the options and outcomes for a disease where survival rates have remained low.
Project leaders include Dr Claus Jorgensen, an expert in pancreas cancer biology at the Cancer Research UK Manchester Institute, who lives in Brooklands.
Altrincham-based Professor Caroline Dive, Cancer Research UK Manchester Institute’s Deputy Director and an expert in so-called liquid biopsies, is also among the project leaders.
Around 1,000 people are diagnosed with pancreatic cancer in the North West every year, with around 930 people dying from the disease in the region every year.
Scientists from the Cancer Research UK Manchester Institute, based at The University of Manchester, will work with experts at The Christie NHS Foundation Trust and with researchers across the UK on the project to develop new treatments for pancreatic cancer using a network of clinical trials, aiming to find the right trial for the right patient.